Abstract
Prospects for the development of vaccines against herpes simplex virus types 1 and 2 and other herpesvirus group vaccines are discussed from the scientific, medical, and economic standpoints. Probably, the most practical development will be glycoprotein subunit vaccines, prepared from herpes simples virus types 1 and 2, that will be tested for prophylaxis and therapy of acute viral disease and for cancer that may be caused by these agents.
摘要
从科学、医学和经济角度讨论了针对1型和2型单纯疱疹病毒疫苗以及其他疱疹病毒组疫苗的开发前景。也许，最切实可行的进展将是由1型和2型单纯疱疹病毒制备的糖蛋白亚单位疫苗，该疫苗将用于急性病毒性疾病的预防和治疗以及由这些病原体可能引发的癌症的防治测试。
Zotero 插件